Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis

Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis

BackgroundThe efficacy and safety of the administration of recombinant human thrombopoietin (rhTPO) in sepsis patients with thrombocytopenia were still inconclusive.ObjectivesTo investigate whether rhTPO is a benefit for sepsis patients with thrombocytopenia.MethodsPubMed, Cochrane library, Embase,...

Full description

Bibliographic Details
Main Authors:	Jin Zhang, Zongqing Lu, Wenyan Xiao, Tianfeng Hua, Yao Zheng, Min Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Pharmacology
Subjects:	sepsis thrombocytopenia recombinant human thrombopoietin (rhTPO) platelet sepsis-related thrombocytopenia
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2020.00940/full

Similar Items

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
by: Qiuhua Zhu, et al.
Published: (2021-08-01)

Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study
by: Yu Liu, et al.
Published: (2020-09-01)

The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)
by: Zhigang Zhou, et al.
Published: (2019-09-01)

The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients
by: Hasan Md. Jahidul, et al.
Published: (2019-11-01)

Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01)

Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case series
by: Guido Lancman, et al.
Published: (2020-09-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01)

Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Chunlu Li, et al.
Published: (2019-07-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2018-01-01)

Economic Evaluation of Rituximab + Recombinant Human Thrombopoietin vs. Rituximab for the Treatment of Second-Line Idiopathic Thrombocytopenic Purpura in China
by: Mingjun Rui, et al.
Published: (2021-03-01)

The pathophysiology of thrombocytopenia in chronic liver disease
by: Mitchell O, et al.
Published: (2016-04-01)

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
by: Heng Mei, et al.
Published: (2021-02-01)

Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells
by: Guntur Berlian, et al.
Published: (2017-05-01)

Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial
by: Mei-feng Li, et al.
Published: (2017-05-01)

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice
by: Monica Carpenedo, et al.
Published: (2015-02-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy
by: Buchbinder D, et al.
Published: (2017-03-01)

Incidence of thrombocytopenia and changes in various platelet parameters, in blood culture positive neonatal sepsis
by: Sartaj Bhat, et al.
Published: (2015-07-01)

Petechial Hemorrhage: A clinical diagnosis of neonatal Thrombocytopenia and sepsis
by: Deepak Kumar sharma, et al.
Published: (2015-02-01)

Petechial Hemorrhage: A clinical diagnosis of neonatal Thrombocytopenia and sepsis
by: Deepak sharma, et al.
Published: (2015-02-01)

A Case of Thrombocytopenia due to Odontogenic Infection
by: Dinesh Kumar Verma, et al.
Published: (2011-12-01)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
by: Cheloff AZ, et al.
Published: (2019-09-01)

Comparative Efficacy and Safety of Thrombopoietin Receptor Agonists in Adults With Thrombocytopenia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trial
by: Junzhu Deng, et al.
Published: (2021-07-01)

PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA
by: Roberto Stasi, et al.
Published: (2009-11-01)

Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
by: Saeed H., et al.
Published: (2020-01-01)

Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern
by: Adam Cuker, et al.
Published: (2021-08-01)

GPIbα is the driving force of hepatic thrombopoietin generation
by: Danielle Karakas, et al.
Published: (2021-05-01)

New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach
by: Naveed Ali, et al.
Published: (2017-07-01)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
by: José María Bastida, et al.
Published: (2021-04-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care
by: Kosaku Hatanaka, et al.
Published: (2021-09-01)

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
by: Isabelle Plo, et al.
Published: (2017-09-01)

Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report
by: Sabah E. Mohamed, et al.
Published: (2020-07-01)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
by: Francesca Palandri, et al.
Published: (2012-06-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Platelets in Sepsis: An Update on Experimental Models and Clinical Data
by: Alice Assinger, et al.
Published: (2019-07-01)

Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia
by: Cui YL, et al.
Published: (2016-03-01)

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)